25 Results for "

ranolazine-

" in MedChemExpress (MCE) Product Catalog:
Products (25)

25 Results for "ranolazine-" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-B0280
CAS No.: 95635-55-5
Synonyms: CVT 303; RS 43285-003
Ranolazine (CVT 303) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor . Antianginal agent.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-17401
CAS No.: 95635-56-6
Synonyms: CVT 303 dihydrochloride; RS 43285
Ranolazine dihydrochloride (CVT 303 dihydrochloride) is an anti-angina agent that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine dihydrochloride is also a partial fatty acid oxidation inhibitor .
loading...
    loading...
Cat. No.: HY-W009512
CAS No.: 5294-61-1
Synonyms: RS-94287
Target:  

Drug Metabolite

Research Areas:  

Cardiovascular Disease

CVT-2738 is an orally active metabolite of Ranolazine (HY-B0280). CVT-2738 has a protective effect against Isoprenaline (HY-108353)-induced myocardial ischemia in mice. CVT-2738 can be used in myocardial ischemia research .
loading...
    loading...
Cat. No.: HY-B0280S1
CAS No.: 1092804-88-0
Ranolazine-d8 is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti-angina agent that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor . Antianginal agent.
loading...
    loading...
Cat. No.: HY-B0280S2
CAS No.: 1054624-77-9
Ranolazine-d3 is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti-angina agent that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor . Antianginal agent.
loading...
    loading...
Cat. No.: HY-17401S
CAS No.: 1219802-60-4
Synonyms: CVT 303-d8 dihydrochloride; RS 43285-d8
Ranolazine-d8 (dihydrochloride) is the deuterium labeled Ranolazine dihydrochloride. Ranolazine dihydrochloride (CVT 303 dihydrochloride) is an anti-angina agent that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine dihydrochloride is also a partial fatty acid oxidation inhibitor .
loading...
    loading...
Cat. No.: HY-17401R
CAS No.: 95635-56-6
Synonyms: CVT 303 dihydrochloride (Standard); RS 43285 (Standard)
Ranolazine (dihydrochloride) (Standard) is the analytical standard of Ranolazine (dihydrochloride). This product is intended for research and analytical applications. Ranolazine dihydrochloride (CVT 303 dihydrochloride) is an anti-angina agent that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine dihydrochloride is also a partial fatty acid oxidation inhibitor .
loading...
    loading...
Cat. No.: HY-B0280S
CAS No.: 1092804-87-9
Synonyms: CVT 303-d5; RS 43285-003-d5
Ranolazine-d5 is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor . Antianginal agent.
loading...
    loading...
Cat. No.: HY-132694S
CAS No.: 1329834-18-5
Desmethyl Ranolazine-d5 is the deuterium labeled Desmethyl Ranolazine .
loading...
    loading...
Cat. No.: HY-W700344
CAS No.: 172430-45-4
Synonyms: CVT-2514; RS-88390
Target:  

Drug Metabolite

Research Areas:  

Cardiovascular Disease

o-Desmethyl ranolazine (CVT-2514; RS-88390) is a metabolite of Ranolazine (HY-B0280), formed through metabolism of Ranolazine by enzymes of the cytochrome P450 (CYP) 3A family .
loading...
    loading...
Cat. No.: HY-B0280R
CAS No.: 95635-55-5
Synonyms: CVT 303 (Standard); RS 43285-003 (Standard)
Ranolazine (Standard) is the analytical standard of Ranolazine. This product is intended for research and analytical applications. Ranolazine (CVT 303) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP) . Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor . Antianginal agent.
loading...
    loading...
Cat. No.: HY-W700345
CAS No.: 172300-93-5
Desmethyl ranolazine β-D-glucuronide is a class of biochemical reagents used in glycobiology research. Glycobiology studies the structure, synthesis, biology and evolution of sugars. It involves carbohydrate chemistry, enzymology of glycan formation and degradation, protein-Glycan recognition and the role of glycans in biological systems. This field is closely related to basic research, biomedicine and biotechnology.
loading...
    loading...
Cat. No.: HY-103641AR
CAS No.: 1391194-64-1
Synonyms: (2S)-Octyl-2-HG (Standard)
Research Areas:  

Cancer

CVT-2738 (Standard) is the analytical standard of CVT-2738. This product is intended for research and analytical applications. CVT-2738 is a Ranolazine (HY-B0280) Metabolite, and shows anti-myocardial ischemia activities .
loading...
    loading...
Cat. No.: HY-W704005
CAS No.: 755711-09-2
Synonyms: ranolazine impurity B; Desmethoxy ranolazine
Target:  

Drug Intermediate

Research Areas:  

Others

Ranolazine impurity 4 (Ranolazine impurity B) is an impurity of Ranolazine.
loading...
    loading...
Cat. No.: HY-W518419
CAS No.: 380204-72-8
Synonyms: ranolazine impurity D
Target:  

Drug Intermediate

Research Areas:  

Others

Ranolazine impurity 3 (Ranolazine impurity D) is an impurity of Ranolazine.
loading...
    loading...
Cat. No.: HY-W701756
CAS No.: 1246816-00-1
Synonyms: ranolazine bis(N-oxide)
Target:  

Drug Intermediate

Research Areas:  

Others

Ranolazine impurity 1 (Ranolazine bis(N-oxide)) is an impurity of Ranolazine.
loading...
    loading...
Cat. No.: HY-W009512R
CAS No.: 5294-61-1
Synonyms: RS-94287 (Standard)
CVT-2738 (Standard) is the analytical standard of CVT-2738. This product is intended for research and analytical applications. CVT-2738 is an orally active metabolite of Ranolazine (HY-B0280). CVT-2738 has a protective effect against isoprenaline (HY-108353)-induced myocardial ischemia in mice. CVT-2738 can be used in myocardial ischemia research .
loading...
    loading...
Cat. No.: HY-W009512S1
CAS No.: 1054624-93-9
Synonyms: RS-94287-d6
N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide-d6 (N-[(2-chlorophenyl)carbamoyl]phenylalanine-d6) is deuterium-labeled CVT-2738 (HY-W009512). CVT-2738 is an orally active metabolite of Ranolazine (HY-B0280). CVT-2738 has a protective effect against isoprenaline (HY-108353)-induced myocardial ischemia in mice. CVT-2738 can be used in myocardial ischemia research .
loading...
    loading...
Cat. No.: HY-W016487
CAS No.: 2210-74-4
Target:  

Drug Intermediate

Research Areas:  

Others

Ranolazine impurity 10 is an impurity of Ranolazine.
loading...
    loading...
Cat. No.: HY-120336
CAS No.: 172430-46-5
Target:  

Drug Intermediate

Research Areas:  

Others

Ranolazine impurity 9 is an impurity of Ranolazine.
loading...
    loading...